A summarised guide to Cell and Gene Therapy

The advantages to building a business in the UK's biotech clusters

Each month, our Policy and Public Affairs team will showcase how we are championing members’ voices in Government and Parliament.

Up to $110 million upfront and success-based milestones collaboration will generate large-scale human cellular perturbation datasets to advance understanding of disease biology.

eXmoor Pharma and Evox Therapeutics announce the successful completion of a technology transfer programme for Evox’s exosome-enabled gene editing technology.

The Milner Therapeutics Institute has joined the o2h Discovery Platinum Partner Programme, enabling eligible companies within its bio-incubator and wider affiliate network to access specialist drug discovery support through the o2h Kickstarter Award.

Poolbeg Pharma today announces that the first patient has been dosed in the POLB 001 TOPICAL clinical trial.